These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 212754)

  • 21. Suppression of cytotoxic responses by a supernatant factor derived from Mycoplasma hyorhinis-infected mammalian cell lines.
    Teh HS; Ho M; Williams LD
    Infect Immun; 1988 Jan; 56(1):197-203. PubMed ID: 3257204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen.
    Cole BC; Atkin CL
    Immunol Today; 1991 Aug; 12(8):271-6. PubMed ID: 1910449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ; Lyles DS; Harris DT
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    Proust JJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycoplasma hyorhinis-Contaminated Cell Lines Activate Primary Innate Immune Cells via a Protease-Sensitive Factor.
    Heidegger S; Jarosch A; Schmickl M; Endres S; Bourquin C; Hotz C
    PLoS One; 2015; 10(11):e0142523. PubMed ID: 26565413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycoplasma-lymphocyte interactions and their possible role in immunopathologic manifestations of mycoplasmal disease.
    Stanbridge EJ
    Rev Infect Dis; 1982; 4 Suppl():S219-26. PubMed ID: 6126923
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization and application of monoclonal antibodies against Mycoplasma hyorhinis pyruvate dehydrogenase E1 complex subunit alpha.
    Chen D; Wei Y; Huang L; Wang Y; Du W; Sun J; Wu H; Feng L; Liu C
    Appl Microbiol Biotechnol; 2016 Apr; 100(8):3587-97. PubMed ID: 26743652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The regulation of murine B cell differentiation. I. Nonspecific suppression caused by Mycoplasma arginini.
    Foresman MD; Sheehan KC; Swierkosz JE
    Cell Immunol; 1989 Oct; 123(2):354-72. PubMed ID: 2790965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and partial characterization of the human homologue of Thy-1.
    Ades EW; Zwerner RK; Acton RT; Balch CM
    J Exp Med; 1980 Feb; 151(2):400-6. PubMed ID: 6153212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-lymphocyte differentiation is accompanied by increase in sialic acid content of Thy-1 antigen.
    Hoessli D; Bron C; Pink JR
    Nature; 1980 Feb; 283(5747):576-8. PubMed ID: 6965519
    [No Abstract]   [Full Text] [Related]  

  • 31. Production of antigen-specific suppressive T cell factor by radiation leukemia virus-transformed suppressor T cells.
    Ricciardi-Castagnoli P; Doria G; Adorini L
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3804-8. PubMed ID: 6267605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.
    Citti C; Kim MF; Wise KS
    Infect Immun; 1997 May; 65(5):1773-85. PubMed ID: 9125561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T lymphocyte responses are critical determinants in the pathogenesis and resistance to mycoplasma respiratory disease.
    Jones HP; Simecka JW
    Front Biosci; 2003 May; 8():d930-45. PubMed ID: 12700085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of mycoplasma on the production of the oncogenic leukemia virus HTLV by HUT-102 T-lymphoblastoid cells].
    Alymbaeva DB; Miller GG; Rakovskaia IV; Bykovskiĭ AF
    Vopr Virusol; 1985; 30(1):75-8. PubMed ID: 2986357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of Mycoplasma hyorhinis by CD99-Fc molecule.
    Gazit R; Rechnitzer H; Achdout H; Katzenell A; Katz G; Markel G; Arnon TI; Gonen-Gross T; Mizrahi S; Gruda R; Rottem S; Mandelboim O
    Eur J Immunol; 2004 Jul; 34(7):2032-40. PubMed ID: 15214051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenetics of cell surface antigens of mouse leukemia.
    Old LJ; Stockert E
    Annu Rev Genet; 1977; 11():127-60. PubMed ID: 202188
    [No Abstract]   [Full Text] [Related]  

  • 37. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. IV. Murine T hybridoma cells exhibit differential accessory cell requirements for activation by M. arthritidis T cell mitogen, concanavalin A, or hen egg-white lysozyme.
    Cole BC; Araneo BA; Sullivan GJ
    J Immunol; 1986 May; 136(10):3572-8. PubMed ID: 3486214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis.
    Riethman HC; Boyer MJ; Wise KS
    Infect Immun; 1987 May; 55(5):1094-100. PubMed ID: 2437031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera.
    Peters CJ; Theofilopoulos AN
    J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.